HUTCHMED (China) Ltd Files Routine 6-K Disclosure
Ticker: HMDCF · Form: 6-K · Filed: Oct 16, 2024 · CIK: 1648257
Sentiment: neutral
Topics: sec-filing, routine-disclosure, foreign-private-issuer
TL;DR
HUTCHMED filed a 6-K, standard disclosure, no major news.
AI Summary
HUTCHMED (China) Limited filed a Form 6-K on October 16, 2024, reporting its status as a foreign private issuer. The filing does not contain specific financial updates or material events but serves as a routine disclosure for the month of October 2024.
Why It Matters
This filing indicates ongoing compliance and reporting by HUTCHMED as a foreign private issuer with the SEC, which is standard for companies listed on US exchanges.
Risk Assessment
Risk Level: low — This is a routine filing with no new material information or financial updates, thus posing minimal immediate risk.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- 001-37710 (company) — SEC File Number
- 20241016 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of October 2024.
Who is the filer of this report?
The filer is HUTCHMED (China) Limited.
What is the SEC file number for HUTCHMED (China) Limited?
The SEC file number is 001-37710.
What is the principal executive office address of HUTCHMED (China) Limited?
The principal executive office is located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Does HUTCHMED (China) Limited file annual reports under Form 20-F or 40-F?
The filing indicates that HUTCHMED (China) Limited files annual reports under cover of Form 20-F.
Filing Stats: 184 words · 1 min read · ~1 pages · Grade level 14.9 · Accepted 2024-10-16 06:19:46
Filing Documents
- hcm-20241016x6k.htm (6-K) — 20KB
- hcm-20241016xex99d1.htm (EX-99.1) — 46KB
- hcm-20241016xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-24-000078.txt ( ) — 73KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Announcement relating to HUTCHMED announces that TAGRISSO plus ORPATHYS demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH phase II trial 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: October 16, 2024 3